Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BS.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.453ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.637.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.79ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XASENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.317ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-19910.8Singapore
B.1.1.486SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-19906.7Japan
B.1.351 (Beta)SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-19906.7Japan
XBB.1.5.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-19891.3Japan
XBB.1.5.58NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19883.7Germany
XBB.2.3.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.96NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.8.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BR.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.79NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FD.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used